• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬菌体疗法在调控多重耐药性方面的最新进展,包括在人类和家禽领域。

Recent Progress in Phage Therapy to Modulate Multidrug-Resistant , including in Human and Poultry.

作者信息

Zhang Yan, Lin Yuanqing, Galgano Salvatore, Houdijk Jos, Xie Weiquan, Jin Yajie, Lin Jiameng, Song Wuqiang, Fu Yijuan, Li Xiuying, Chui Wenting, Kan Wei, Jia Cai, Hu Guangwei, Li Tao

机构信息

Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences (CAAS), Shanghai 200241, China.

Animal Disease Prevention and Control Center in Qinghai Province, Xining 810001, China.

出版信息

Antibiotics (Basel). 2022 Oct 13;11(10):1406. doi: 10.3390/antibiotics11101406.

DOI:10.3390/antibiotics11101406
PMID:36290064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9598230/
Abstract

is a multidrug-resistant and invasive pathogen associated with the etiopathology of both an increasing number of nosocomial infections and is of relevance to poultry production systems. Multidrug-resistant has been reported in connection to severe challenges to clinical treatment, mostly due to an increased rate of resistance to carbapenems. Amid the possible strategies aiming to reduce the insurgence of antimicrobial resistance, phage therapy has gained particular importance for the treatment of bacterial infections. This review summarizes the different phage-therapy approaches currently in use for multiple-drug resistant , including single phage therapy, phage cocktails, phage-antibiotic combination therapy, phage-derived enzymes active on and some novel technologies based on phage interventions. Although phage therapy represents a potential treatment solution for multidrug-resistant , further research is needed to unravel some unanswered questions, especially in regard to its in vivo applications, before possible routine clinical use.

摘要

是一种多重耐药且具有侵袭性的病原体,与越来越多的医院感染的病因病理学相关,并且与家禽生产系统有关。已报道多重耐药菌给临床治疗带来严重挑战,主要原因是对碳青霉烯类药物的耐药率增加。在旨在减少抗菌药物耐药性出现的可能策略中,噬菌体疗法在治疗细菌感染方面变得尤为重要。本综述总结了目前用于多重耐药菌的不同噬菌体疗法,包括单一噬菌体疗法、噬菌体鸡尾酒疗法、噬菌体 - 抗生素联合疗法、对[细菌名称未明确给出]有活性的噬菌体衍生酶以及一些基于噬菌体干预的新技术。尽管噬菌体疗法是多重耐药菌的一种潜在治疗方案,但在可能的常规临床应用之前,还需要进一步研究来解决一些未解答的问题,特别是关于其体内应用方面的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eddd/9598230/06aa51cfa51e/antibiotics-11-01406-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eddd/9598230/06aa51cfa51e/antibiotics-11-01406-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eddd/9598230/06aa51cfa51e/antibiotics-11-01406-g001.jpg

相似文献

1
Recent Progress in Phage Therapy to Modulate Multidrug-Resistant , including in Human and Poultry.噬菌体疗法在调控多重耐药性方面的最新进展,包括在人类和家禽领域。
Antibiotics (Basel). 2022 Oct 13;11(10):1406. doi: 10.3390/antibiotics11101406.
2
Genetic Signatures from Adaptation of Bacteria to Lytic Phage Identify Potential Agents To Aid Phage Killing of Multidrug-Resistant Acinetobacter baumannii.细菌对溶菌噬菌体适应的遗传特征可鉴定出有助于噬菌体杀灭多重耐药鲍曼不动杆菌的潜在药物。
J Bacteriol. 2022 Mar 15;204(3):e0059321. doi: 10.1128/jb.00593-21. Epub 2022 Feb 14.
3
Bacteriophages and their derived enzymes as promising alternatives for the treatment of Acinetobacter baumannii infections.噬菌体及其衍生酶作为治疗鲍曼不动杆菌感染的有前途的替代品。
Arch Virol. 2023 Nov 10;168(12):288. doi: 10.1007/s00705-023-05910-7.
4
Bactericidal Synergism between Phage YC#06 and Antibiotics: a Combination Strategy to Target Multidrug-Resistant Acinetobacter baumannii and .噬菌体YC#06与抗生素之间的杀菌协同作用:一种针对多重耐药鲍曼不动杆菌的联合策略 以及 。(原文最后and后似乎内容不完整)
Microbiol Spectr. 2022 Aug 31;10(4):e0009622. doi: 10.1128/spectrum.00096-22. Epub 2022 Jun 23.
5
Isolation of a lytic bacteriophage against extensively drug-resistant Acinetobacter baumannii infections and its dramatic effect in rat model of burn infection.分离针对广泛耐药鲍曼不动杆菌感染的溶菌噬菌体及其在烧伤感染大鼠模型中的显著效果。
J Clin Lab Anal. 2022 Jul;36(7):e24497. doi: 10.1002/jcla.24497. Epub 2022 Jun 16.
6
Preoptimized phage cocktail for use in aerosols against nosocomial transmission of carbapenem-resistant Acinetobacter baumannii: A 3-year prospective intervention study.用于气溶胶中针对耐碳青霉烯类鲍曼不动杆菌医院内传播的预优化噬菌体鸡尾酒:一项为期 3 年的前瞻性干预研究。
Ecotoxicol Environ Saf. 2022 May 1;236:113476. doi: 10.1016/j.ecoenv.2022.113476. Epub 2022 Mar 31.
7
Isolation and Characterization of a Novel Phage and Its Combined Effect with Tigecycline in Controlling Multidrug-Resistant -Associated Skin and Soft Tissue Infections.新型噬菌体的分离与鉴定及其与替加环素联合应用对控制多重耐药相关皮肤软组织感染的效果。
Viruses. 2022 Jan 20;14(2):194. doi: 10.3390/v14020194.
8
Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host.开发一种抗鲍曼不动杆菌生物膜噬菌体鸡尾酒:宿主基因组的适应性。
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0192321. doi: 10.1128/AAC.01923-21. Epub 2022 Jan 18.
9
Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.噬菌体治疗对粘质沙雷氏菌在金斑蝶幼虫和急性肺炎小鼠模型中的抗药性的疗效。
BMC Microbiol. 2019 Apr 2;19(1):70. doi: 10.1186/s12866-019-1443-5.
10
Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii.噬菌体鸡尾酒控制多重耐药鲍曼不动杆菌噬菌体耐药性发展的疗效。
Virus Res. 2019 Oct 15;272:197734. doi: 10.1016/j.virusres.2019.197734. Epub 2019 Aug 26.

引用本文的文献

1
Evolutionary dynamics and research hotspots of phage applications against infections from the past to the new era.从过去到新时代噬菌体抗感染应用的进化动力学与研究热点
Front Microbiol. 2025 Jun 24;16:1606351. doi: 10.3389/fmicb.2025.1606351. eCollection 2025.
2
Nanoparticle-based antifungal therapies innovations mechanisms and future prospects.基于纳米颗粒的抗真菌疗法:创新、机制与未来展望
PeerJ. 2025 Apr 8;13:e19199. doi: 10.7717/peerj.19199. eCollection 2025.
3
Whole-genome evaluation and prophages characterization associated with genome of carbapenem-resistant Acinetobacter baumannii UOL-KIMZ-24-2.

本文引用的文献

1
PhageScore-based analysis of Acinetobacter baumannii infecting phages antibiotic interaction in liquid medium.基于噬菌体评分的液体培养基中感染鲍曼不动杆菌的噬菌体-抗生素相互作用分析。
Arch Microbiol. 2022 Jun 24;204(7):421. doi: 10.1007/s00203-022-03020-7.
2
Endolysin, a Promising Solution against Antimicrobial Resistance.内溶素,一种对抗抗生素耐药性的有前景的解决方案。
Antibiotics (Basel). 2021 Oct 20;10(11):1277. doi: 10.3390/antibiotics10111277.
3
Discovering the Potentials of Four Phage Endolysins to Combat Gram-Negative Infections.
与耐碳青霉烯鲍曼不动杆菌UOL-KIMZ-24-2基因组相关的全基因组评估和原噬菌体特征分析
Curr Genet. 2025 Jan 24;71(1):4. doi: 10.1007/s00294-024-01307-4.
4
Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections.推进噬菌体疗法:针对细菌感染靶向治疗的安全性、有效性及未来前景的全面综述
Infect Dis Rep. 2024 Nov 28;16(6):1127-1181. doi: 10.3390/idr16060092.
5
Characterization of bacteriophage vB_AbaS_SA1 and its synergistic effects with antibiotics against clinical multidrug-resistant Acinetobacter baumannii isolates.噬菌体 vB_AbaS_SA1 的特性及其与抗生素联合对抗临床多重耐药鲍曼不动杆菌分离株的协同作用。
Pathog Dis. 2024 Feb 7;82. doi: 10.1093/femspd/ftae028.
6
A review of the fighting Acinetobacter baumannii on three fronts: antibiotics, phages, and nanoparticles.综述鲍曼不动杆菌的三种对抗策略:抗生素、噬菌体和纳米颗粒。
Mol Biol Rep. 2024 Oct 8;51(1):1044. doi: 10.1007/s11033-024-09979-4.
7
The Contribution of Dairy Bedding and Silage to the Dissemination of Genes Coding for Antimicrobial Resistance: A Narrative Review.奶牛垫料和青贮饲料在编码抗菌药物耐药性基因传播中的作用:一项叙述性综述
Antibiotics (Basel). 2024 Sep 22;13(9):905. doi: 10.3390/antibiotics13090905.
8
Unveiling the Secrets of : Resistance, Current Treatments, and Future Innovations.揭示 :耐药性、当前治疗方法和未来创新的秘密。
Int J Mol Sci. 2024 Jun 21;25(13):6814. doi: 10.3390/ijms25136814.
9
Characterization and efficacy against carbapenem-resistant of a novel phage from sewage.从污水中分离的新型噬菌体的特性及其对碳青霉烯类耐药菌的疗效。
Front Cell Infect Microbiol. 2024 Apr 22;14:1382145. doi: 10.3389/fcimb.2024.1382145. eCollection 2024.
10
Host range expansion of Acinetobacter phage vB_Ab4_Hep4 driven by a spontaneous tail tubular mutation.由自发的尾管突变驱动的不动杆菌噬菌体vB_Ab4_Hep4的宿主范围扩展
Front Cell Infect Microbiol. 2024 Feb 16;14:1301089. doi: 10.3389/fcimb.2024.1301089. eCollection 2024.
探索四种噬菌体溶菌酶对抗革兰氏阴性菌感染的潜力。
Front Microbiol. 2021 Oct 13;12:748718. doi: 10.3389/fmicb.2021.748718. eCollection 2021.
4
Black box of phage-bacterium interactions: exploring alternative phage infection strategies.噬菌体-细菌相互作用的黑箱:探索替代噬菌体感染策略。
Open Biol. 2021 Sep;11(9):210188. doi: 10.1098/rsob.210188. Epub 2021 Sep 15.
5
Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals.多重耐药鲍曼不动杆菌在医院的新关注点。
Mol Biol Rep. 2021 Oct;48(10):6987-6998. doi: 10.1007/s11033-021-06690-6. Epub 2021 Aug 30.
6
A photo-sensitizable phage for multidrug-resistant therapy and biofilm ablation.一种用于多药耐药治疗和生物膜消融的光敏噬菌体。
Chem Sci. 2020 Nov 16;12(3):1054-1061. doi: 10.1039/d0sc04889e.
7
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.工程噬菌体疗法:原理、挑战与未来。
BioDrugs. 2021 May;35(3):255-280. doi: 10.1007/s40259-021-00480-z. Epub 2021 Apr 21.
8
Bacteriophage cocktail supplementation improves growth performance, gut microbiome and production traits in broiler chickens.噬菌体鸡尾酒补充剂可改善肉鸡的生长性能、肠道微生物群和生产性能。
J Anim Sci Biotechnol. 2021 Apr 16;12(1):49. doi: 10.1186/s40104-021-00570-6.
9
Phage φAB6-Borne Depolymerase Combats Biofilm Formation and Infection.噬菌体φAB6携带的解聚酶对抗生物膜形成和感染。
Antibiotics (Basel). 2021 Mar 9;10(3):279. doi: 10.3390/antibiotics10030279.
10
A Novel Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes.一种新型溶菌酶 LysAB54,对多种革兰氏阴性菌具有高效抗菌活性。
Front Cell Infect Microbiol. 2021 Mar 2;11:637313. doi: 10.3389/fcimb.2021.637313. eCollection 2021.